Results 111 to 120 of about 1,098 (175)
Some of the next articles are maybe not open access.
ChemSusChem, 2022
AbstractNatural phenethyl acetate (PEA), phenylacetic acid (PAA), ethyl phenylacetate (Et‐PA), and phenethyl phenylacetate (PE‐PA) are highly desirable aroma chemicals, but with limited availability and high price. Here, green, sustainable, and efficient bioproduction of these chemicals as natural products from renewable feedstocks was developed.
Balaji Sundara Sekar, Xirui Li, Zhi Li
openaire +2 more sources
AbstractNatural phenethyl acetate (PEA), phenylacetic acid (PAA), ethyl phenylacetate (Et‐PA), and phenethyl phenylacetate (PE‐PA) are highly desirable aroma chemicals, but with limited availability and high price. Here, green, sustainable, and efficient bioproduction of these chemicals as natural products from renewable feedstocks was developed.
Balaji Sundara Sekar, Xirui Li, Zhi Li
openaire +2 more sources
Journal of Fluorine Chemistry, 2008 Selective electrochemical fluorination of alkyl phenylacetates (Ph–CH2–COOR, where R is methyl, ethyl, n-propyl, n-butyl, i-propyl and secbutyl) under galvanostatic conditions were reported in Et3N4HF medium.
N Ilayaraja, M Noel, D Velayutham
exaly +1 more source
Journal of Molecular Structure, 2016 The analysis of the infrared carbonyl bands of some 2-ethylsulfinyl-(4'-substituted)-phenylacetates bearing the substituents NO2(1), Cl(2), Br(3), H(4), Me(5) and OMe(6), along with B3LYP/6-31G(d,p), SM5.42R solvation model calculations and natural bond ...
Maurizio Dal Colle +2 more
exaly +2 more sources
Ornithine phenylacetate revisited
Metabolic Brain Disease, 2013In patients with liver failure hyperammonemia is associated with the development of hepatic encephalopathy (HE) and immune impairment. Treatment of hyperammonemia is an unmet clinical need. Ornithine phenylacetate (OP) is a novel drug that is targeted at reducing ammonia concentration in patients with liver disease and therefore a potential treatment ...
Maria, Jover-Cobos +3 more
openaire +2 more sources
Journal of Neurochemistry, 1979
AbstractIn the rat phenylacetate readily penetrates into such tissues as brain, eyes, heart, kidneys, and liver. One hour after the subcutaneous injection of sodium phenylacetate into rats ranging in age from 1 to 65 days, the ratios of the concentrations (μmolig) in blood/tissue were approx 1:1 in all of these tissues with the exception of the brain ...
Y H, Loo, T, Fulton, H M, Wisniewski
openaire +2 more sources
AbstractIn the rat phenylacetate readily penetrates into such tissues as brain, eyes, heart, kidneys, and liver. One hour after the subcutaneous injection of sodium phenylacetate into rats ranging in age from 1 to 65 days, the ratios of the concentrations (μmolig) in blood/tissue were approx 1:1 in all of these tissues with the exception of the brain ...
Y H, Loo, T, Fulton, H M, Wisniewski
openaire +2 more sources
Enzymatic conversion of phenylpyruvate to phenylacetate
Biochimica et Biophysica Acta (BBA) - General Subjects, 1968Using Acromobacter eurydice isolated from soil, we clarified the pathway by which phenylpyruvate is metabolized to phenylacetate through phenylacetaldehyde. We defined the enzymes concerned as phenylpyruvate decarboxylase and phenylacetaldehyde dehydrogenase. Phenylpyruvate decarboxylase was purified and some of its properties were studied.
T, Asakawa, H, Wada, T, Yamano
openaire +2 more sources
Phenylacetic acid excretion in man
Analytical Biochemistry, 1979A rapid, reliable, sensitive, and highly specific mass fragmentographic method for the quantification of phenylacetic acid (PAA) in urine is described. The method was used to determine total, conjugated, and free PAA simultaneously in normal urine. The mean ± SE excretion of total, conjugated, and free PAA in urine of 24 normal adult volunteers were ...
M E, Martin, F, Karoum, R J, Wyatt
openaire +2 more sources
THE METABOLISM OF PHENYLACETIC ACID BY A PSEUDOMONAS
Canadian Journal of Microbiology, 1967A Pseudomonas species adapted to grow on phenylacetic acid is simultaneously adapted to the utilization of phenylacetic acid, p-hydroxyphenylacetic acid, and 3,4-dihydroxyphenylacetic acid. Extracts of the organism catalyze the oxidation of p-hydroxyphenylacetic acid and 3,4-dihydroxyphenylacetic acid, but not phenylacetic acid.
E R, Blakley +3 more
openaire +2 more sources
Photolysis of phenylacetic acid and methyl phenylacetate in methanol
Journal of the American Chemical Society, 1972Theodore O. Meiggs, Sidney I. Miller
openaire +1 more source
Acta Crystallographica Section C Crystal Structure Communications, 1991
D. J. Hodgson, R. O. Asplund
openaire +1 more source
D. J. Hodgson, R. O. Asplund
openaire +1 more source